BBP-18295 Yellow
Cc1cc(Nc2nc(-c3ccc(F)c(Cl)c3)nc3cc(N4CCN(C)CC4)ncc23)n[nH]1
0.454
Platform Score
2D Structure
C22H22ClFN8 | Exact mass: 452.164
Key Metrics
-7.2
Vina (kcal/mol)
#1313
Docking Rank
1
Hinge Binder
86
TPSA
453
MW
2
HBD
4.0
SlogP
Display Controls
PLK4 Docking Result
-7.21
kcal/mol (molecular docking)
| Docking Rank | #1313 of 1,249 |
| Consensus Score | 0.2427 |
| Receptor | PLK4 (PDB: 4YUR) |
| Selective | No |
Selectivity Profile
ADMET Profile
| BBB (BOILED-Egg) | BBB- (non-penetrant) |
| ADMET Status | Pass (no hard fails) |
| hERG Risk | pIC50 0.9 (low risk) |
| AMES Mutagenicity | Negative |
| Efflux Risk (P-gp) | P-gp Substrate — likely effluxed at BBB. ER predicted >2.0 |
| Intestinal Absorption | High |
| 3D PSA | 59.0 A² (CNS-favorable) |
| MDCK Perm (predicted) | -4.77 log Papp (good) |
| CYP3A4 Inhibitor | Inhibitor |
| Hepatotoxicity | Positive |
Flags: ["hepatotox_positive", "P-gp_substrate", "CYP3A4_inhibitor"]
CNS Drug-Likeness
Physicochemical Properties
| Molecular Weight | 452.93 Da |
| TPSA | 85.9 A^2 |
| HBD | 2 |
| HBA | 7 |
| SlogP | 4.01 |
| Fsp3 | 0.273 |
| Rotatable Bonds | 4 |
| Rings | 5 (4 aromatic) |
| QED | 0.483 |
| SA Score | 2.75 (1=easy, 10=hard) |
| CNS MPO | 1.76 / 4.0 |
| Formula | C22H22ClFN8 |
| Exact Mass | 452.164 |
Classification
| Scaffold (Murcko) | C1CCC(C2CCC3C(CC4CCCC4)CC(C4CCCCC4)CC3C2)CC1 |
| Source Versions | v13,v14 |
| Best Source Score | 0.6408 |
| Best Source Rank | #71 |
| Hinge Binder | Aminopyrazole DAD |
| InChIKey | CJZFYTTVGZSDKP-UHFFFAOYSA-N |
| Filter Pass | Yes |
Retrosynthetic Analysis
Retrosynthetic analysis not yet run for this compound.
About
Retrosynthetic analysis decomposes the target molecule into purchasable building blocks using learned reaction templates.
A feasible route means the molecule can theoretically be synthesized from commercially available starting materials.
Min steps indicates the shortest synthesis route found.